NMC Health PLC (NMC)

London

Currency in GBP

9.00

0.00(0.00%)

Closed24/04

Fair Value

Day's Range

9.00

9.00

52 wk Range

0.00

9.00

NMC Income Statement

Featured here, the Income Statement (earnings report) for NMC Health PLC, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2009

31/12

2010

31/12

2011

31/12

2012

31/12

2013

31/12

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

Total Revenues

643.93

880.87

1,220.84

1,603.4

2,057.25

Total Revenues Growth

+16.89%

+36.8%

+38.59%

+31.34%

+28.31%

Cost Of Revenues

434.73

575.93

753.33

968.04

1,216.13

Gross Profit

209.21

304.94

467.51

635.35

841.13

Gross Profit Growth

+12.75%

+45.76%

+53.31%

+35.9%

+32.39%

Gross Profit Margin %

32.49%

34.62%

38.29%

39.63%

40.89%

Other Operating Expenses, Total

120.8

189.92

277.43

352.85

460.54

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+18.12%	+57.22%	+46.07%	+27.19%	+30.52%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	137.19	191.25	267.9	335.17	442.97
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-30.44	-36.65	-46.47	-53.2	-82.79

Operating Income

88.41

115.02

190.08

282.5

380.59

Operating Income Growth

+6.16%

+30.1%

+65.26%

+48.62%

+34.72%

EBIT Margin %

13.73%

13.06%

15.57%

17.62%

18.5%

Net Interest Expenses

-8.7

-19.79

-30.23

-57.87

-121.67

Net Interest Expenses Growth

+25.42%

-127.48%

-52.73%

-91.43%

-110.24%

Interest Expense, Total

-12.32

-20.72

-31.65

-59.94

-125.04

Interest And Investment Income

3.62

0.93

1.42

2.07

3.37

Other Non Operating Expenses, Total

-2.17

-4.28

-0.14

-3.22

-4.39

EBT, Excl. Unusual Items

77.53

90.95

159.72

221.42

254.53

Gain (Loss) On Sale Of Assets

-

-

-

-

-

Other Unusual Items, Total

-

-1.46

-3.54

-5.02

1.67

EBT, Incl. Unusual Items

77.53

85.36

151.58

210.43

256.85

EBT, Incl. Unusual Items Growth

+12.14%

+10.09%

+77.58%

+38.83%

+22.06%

EBT, Incl. Unusual Items Margin

12.04%

9.69%

12.42%

13.12%

12.49%

Income Tax Expense

-

-0.4

0.17

1.25

4.94

Net Income to Company

77.53

85.76

151.4

209.18

251.91

Minority Interest

-0.97

-3.55

-18.71

-23.21

-3.26

Net Income

76.57

82.22

132.69

185.97

248.65

Net Income Growth

+12.32%

+7.38%

+61.39%

+40.15%

+33.71%

Net Income Margin %

11.89%

9.33%

10.87%

11.6%

12.09%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

76.57

82.22

132.69

185.97

248.65

Basic EPS - Continuing Operations

0.41

0.44

0.71

0.91

1.2

Basic EPS - Continuing Operations Growth

+12.32%

+7.38%

+60.6%

+28.03%

+31.4%

Diluted EPS - Continuing Operations

0.41

0.44

0.71

0.9

1.19

Diluted EPS - Continuing Operations Growth

+12.26%

+7.28%

+59.95%

+27.72%

+31.56%

Basic Weighted Average Shares Outstanding

185.71

185.71

186.63

204.3

207.89

Diluted Weighted Average Shares Outstanding

185.77

186.2

187.55

205.84

209.29

Dividend Per Share

0.08

0.09

0.13

0.18

0.23

Dividend Per Share Growth

+15.46%

+8.64%

+43.14%

+34.26%

+31.29%

EBITDA

102.46

149.25

245.26

352.34

479.28

EBITDA Growth

+10.24%

+45.67%

+64.33%

+43.66%

+36.03%

EBITDA Margin %

15.91%

16.94%

20.09%

21.97%

23.3%

EBIT